Biotech

All Articles

Basilea ratings $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's work establishing brand-new antifungals has actually obtained a significant...

Capricor markets Europe liberties to late-stage DMD therapy for $35M

.Possessing presently scooped up the U.S. civil rights to Capricor Rehabs' late-stage Duchenne muscu...

FDA scraps adcomm for Applied's uncommon illness medication

.After pushing the decision meeting for Applied Rehabs' metabolic problem drug govorestat, the FDA h...

Novo inks $600M NanoVation bargain to analyze genetic drugs ex-liver

.Novo Nordisk is proceeding its own press right into genetic medications, accepting compensate NanoV...

Innovent links cytokine to intestines cancer reactions

.Innovent Biologics has actually created the instance that its checkpoint inhibitor-cytokine blend h...

Merck, Daiichi ADC strikes goal in stage 3 bronchi cancer research study

.A phase 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina deepens AI concentrate along with collab to choose cancer cells aim ats

.Five months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech ha...

Ascendis' dwarfism medicine smash hits in period 3, threatens BioMarin

.Ascendis Pharma has emerged as a prospective hazard to BioMarin's Voxzogo, reporting stage 3 growth...

Despite ph. 3 overlook, Alkeus sees road in advance for eye disease property

.Though Alkeus Pharmaceuticals' dental eye ailment property neglected to dramatically lessen geograp...

Kairos goes social with $6M IPO to finance trials of cancer cells medicine

.With a triad of biotechs attacking the Nasdaq on Friday, it was easy to miss out on a smaller-scale...